Results 101 to 110 of about 13,988 (233)
Gastroparesis for the nongastroenterologist
Cleveland Clinic Journal of MedicineGastroparesis is a heterogeneous motility disorder characterized by nausea, vomiting, and postprandial fullness. Its diagnosis requires objective documentation of delayed gastric emptying of solid food and exclusion of mechanical obstruction. Its epidemiology is unclear, and the main causes are diabetes mellitus and idiopathic disease.
Jorge, Araujo-Duran +2 more
openaire +2 more sources
Third Space Endoscopic Therapies for Benign Motility Disorders: A Narrative Review
DEN Open, Volume 7, Issue 1, April 2027.ABSTRACT Objectives To review the evidence base, evolution, outcomes, adverse events (AEs), and management for third‐space endoscopy (TSE) procedures for management of benign motility disorders. Methods This review examines TSE procedures for motility disorders, reviewing the current available techniques, success, outcomes, and long‐term outcomes from ...
Sanjana Bhagwat, Amol Bapaye
wiley +1 more source
Diabetes, Obesity and Metabolism, Volume 28, Issue 10, Page 8757-8768, October 2026.ABSTRACT Background Individuals living with type 1 diabetes (T1D) are at increased risk for cardiovascular (CV) and renal complications, yet therapeutic strategies specifically targeting cardiorenal risk reduction in this population remain limited. The role of glucagon‐like peptide‐1 (GLP‐1)‐based therapies in T1D remains unclear.
Anastasios Tentolouris +5 more
wiley +1 more source
Gastroparesis: Current Concepts and Management
Gut and Liver, 2009 Delayed gastric emptying in the absence of mechanical obstruction is referred to as gastroparesis. Symptoms that are often attributed to gastroparesis include postprandial fullness, nausea, and vomiting.
doaj +1 more source
Diabetes, Obesity and Metabolism, Volume 28, Issue 10, Page 8812-8824, October 2026.ABSTRACT Aims Attaining target glycaemia can be a challenge in Type 1 Diabetes (T1D) due to insulin‐induced weight gain. Adjunct therapy with modern glucose‐lowering agents developed for type 2 diabetes (T2D) has great potential but may be insufficiently efficacious and carries risks of hypoglycaemia and ketosis.
Joseph G. Timmons +11 more
wiley +1 more source
Diabetes, Obesity and Metabolism, Volume 28, Issue 10, Page 8836-8846, October 2026.ABSTRACT Aims To evaluate the effectiveness and safety of tirzepatide on glycaemia, weight, and markers of cardiometabolic risk in people with type 1 diabetes and obesity. Materials and Methods This retrospective cohort study compared 142 adults with type 1 diabetes (BMI ≥ 30 kg/m2) initiated on tirzepatide against 50 age‐, sex‐ and BMI‐matched ...
Simon A. Berry +4 more
wiley +1 more source
Diabetes, Obesity and Metabolism, Volume 28, Issue 10, Page 9178-9187, October 2026.ABSTRACT Aims To evaluate the efficiency of the AID system with Control‐IQ technology and carbohydrate counting (CHC)–based premeal bolus to control postprandial glucose (PPG) after mixed meals with different macronutrient compositions in adolescents with type 1 diabetes (T1D).
Marco Marigliano +8 more
wiley +1 more source
Pylorus‐Preserving Gastrectomy for Gastric Cancer: Current Evidence and Future Directions
Annals of Gastroenterological Surgery, Volume 10, Issue 5, Page 1388-1403, September 2026.This review aims to outline the current evidence and future directions of PPG, focusing on the feasibility of extending its application beyond its traditional indications. ABSTRACT Pylorus‐preserving gastrectomy (PPG) is a function‐preserving surgery for clinically T1N0M0 (cT1N0M0) early gastric cancer (EGC) located in the middle third of the stomach ...
Sa‐Hong Kim, Hyuk‐Joon Lee
wiley +1 more source
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2009 The aim of clinical case presentation. To demonstrate a rare case of the low colic obstruction, masking clinical manifestations of gastroparesis.The main contents.
Z. A. Lemeshko +5 more
doaj